Human basic fibroblast growth factor fused with Kringle4 peptide binds to a fibrin scaffold and enhances angiogenesis

Tissue Engineering - Part A

Volumn 15, Issue 5, 2009, Pages 991-998

  Zhao, Wenxue ^a,b   Han, Qianqian ^a,b   Lin, Hang ^a,b   Sun, Wenjie ^a,b   Gao, Yuan ^a,b   Zhao, Yannan ^a,b   Wang, Bin ^a,b   Wang, Xia ^a,b   Chen, Bing ^a   Xiao, Zhifeng ^a   Dai, Jianwu ^a  

^a INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; BIOACTIVITY; BIOCOMPATIBILITY; CELL CULTURE; FIBROBLASTS; PEPTIDES; THREE DIMENSIONAL;

ANGIOGENESIS; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; BINDING ABILITIES; BINDING PEPTIDE; CELL MIGRATION; FIBRIN SCAFFOLD; IMMUNOHISTOCHEMICAL ANALYSIS; NEOVASCULARIZATION; SIGNAL MOLECULES; SITE-SPECIFIC; TARGETED DELIVERY; THERAPEUTIC ANGIOGENESIS; THREE-DIMENSIONAL (3D) SCAFFOLDS; TISSUE REGENERATION; WOUND REPAIR;

SCAFFOLDS;

BASIC FIBROBLAST GROWTH FACTOR; FIBRIN; FIBRIN DERIVATIVE; PROTEIN KRINGLE4; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KRINGLE DOMAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; TISSUE REGENERATION;

EID: 66249112529     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0240     Document Type: Article

References (24)

1. Rinsch, C., Quinodoz, P., Pittet, B., Alizadeh, N., Baetens, D., Montandon, D., Aebischer, P., and Pepper, M.S. Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia. Gene Ther 8, 523, 2001.
2. Madeddu, P. Therapeutic angiogenesis and vasculogenesis for tissue regeneration. Exp Physiol 90, 315, 2005.
3. Choksy, S.A., and Chan, P. Therapeutic angiogenesis. Br J Surg 93, 261, 2006.
4. Montesano, R., Vassalli, J.D., Baird, A., Guillemin, R., and Orci, L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci U S A 83, 7297, 1986.
5. Aviles, R.J., Annex, B.H., and Lederman, R.J. Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF-2). Br J Pharmacol 140, 637, 2003.
6. Lee, S.H., Wolf, P.L., Escudero, R., Deutsch, R., Jamieson, S.W., and Thistlethwaite, P.A. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342, 626, 2000.
7. Hirose, K., Fujita, M., Marui, A., Arai, Y., Sakaguchi, H., Huang, Y., Chandra, S., Tabata, Y., and Komeda, M. Combined treatment of sustained-release basic fibroblast growth factor and sarpogrelate enhances collateral blood flow effectively in rabbit hindlimb ischemia. Circ J 70, 1190, 2006.
8. Lekas, M., Lekas, P., Latter, D.A., Kutryk, M.B., and Stewart, D.J. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation? Curr Opin Cardiol 21, 376, 2006.
9. Mosesson, M.W., Siebenlist, K.R., and Meh, D.A. The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 936, 11, 2001.
10. Hokugo, A., Takamoto, T., and Tabata, Y. Preparation of hybrid scaffold from fibrin and biodegradable polymer fiber. Biomaterials 27, 61, 2006.
11. Chalupowicz, D.G., Chowdhury, Z.A., Bach, T.L., Barsigian, C., and Martinez, J. Fibrin II induces endothelial cell capillary tube formation. J Cell Biol 130, 207, 1995.
12. Ryan, E.A., Mockros, L.F., Weisel, J.W., and Lorand, L. Structural origins of fibrin clot rheology. Biophys J 77, 2813, 1999.
13. Petersen, T.E., Martzen, M.R., Ichinose, A., and Davie, E.W. Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system. J Biol Chem 265, 6104, 1990.
14. Hochschwender, S.M., and Laursen, R.A. The lysine binding sites of human plasminogen. Evidence for a critical tryptophan in the binding site of kringle 4. J Biol Chem 256, 11172, 1981.
15. Vali, Z., and Patthy, L. The fibrin-binding site of human plasminogen. Arginines 32 and 34 are essential for fibrin affinity of the kringle 1 domain. J Biol Chem 259, 13690, 1984.
16. Zhao, W., Chen, B., Li, X., Lin, H., Sun, W., Zhao, Y., Wang, B., Zhao, Y., Han, Q., and Dai, J. Vascularization and cellularization of collagen scaffolds incorporated with two different collagen-targeting human basic fibroblast growth factors. J Biomed Mater Res A, 2007.
17. Wu, S.C., Yeung, J.C., Duan, Y., Ye, R., Szarka, S.J., Habibi, H.R., and Wong, S.L. Functional production and characterization of a fibrin-specific single-chain antibody fragment from Bacillus subtilis: effects of molecular chaperones and a wall-bound protease on antibody fragment production. Appl Envir Microbiol 68, 3261, 2002.
18. Eyrich, D., Brandl, F., Appel, B., Wiese, H., Maier, G., Wenzel, M., Staudenmaier, R., Goepferich, A., and Blunk, T. Long-term stable fibrin gels for cartilage engineering. Biomaterials 28, 55, 2007.
19. Sahni, A., Odrljin, T., and Francis, C.W. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem 273, 7554, 1998.
20. Cao, R., Brakenhielm, E., Pawliuk, R., Wariaro, D., Post, M.J., Wahlberg, E., Leboulch, P., and Cao, Y. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nature Med 9, 604, 2003.
21. Giavazzi, R., Sennino, B., Coltrini, D., Garofalo, A., Dossi, R., Ronca, R., Tosatti, M.P., and Presta, M. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. Am J Pathol 162, 1913, 2003.
22. Liekens, S., Neyts, J., De Clercq, E., Verbeken, E., Ribatti, D., and Presta, M. Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir. Cancer Res 61, 5057, 2001.
23. Hantgan, R.R., Jerome, W.G., and Hursting, M.J. No effect of clot age or thrombolysis on argatroban's inhibition of thrombin. Blood 92, 2064, 1998.
24. Carmeliet, P. VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nature Med 6, 1102, 2000.